68Ga-A9-6217

N/A

Report date: 2025/11/28 15:16:30

Base Information

Drug Name68Ga-A9-6217

Drug Alias Name68Ga-A9-6217

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlpha-9 Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpha-9 Oncology Inc

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A